Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Update on ReNeuron's ReN-001 stem cell therapy for stroke

Sep. 10, 2007

Extinction of learned responses to fear regulated by Cdk5 signaling in hippocampus / News in Context

Sep. 10, 2007

Positive results for extension of Akela Pharma's phase IIb Fentanyl Taifun trial

Sep. 7, 2007

BioDelivery and Meda enter North American BEMA Fentanyl license agreement

Sep. 7, 2007

Positive results for Next Pharmaceuticals' study of Relora

Sep. 7, 2007

Lundbeck and Takeda to codevelop and comarket new therapies for psychiatric disorders

Sep. 7, 2007

Positive results for Clinical Data's pivotal phase III study of vilazodone for depression

Sep. 6, 2007

Icagen begins phase I study of ICA-105665 for epilepsy

Sep. 6, 2007

USAN approves nonproprietary name adipiplon for Neurogen's NG2-73 for insomnia

Sep. 6, 2007

Ovation initiates U.S. phase III clobazam study in epilepsy

Sep. 6, 2007

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...